<DOC>
	<DOCNO>NCT01982552</DOCNO>
	<brief_summary>The purpose study document quality life , patient satisfaction , effect itching , control psoriasis vulgaris associate use calcipotriene/betamethasone dipropionate ( Taclonex速 ) topical suspension 0.005 % / 0.064 % treatment plaque psoriasis real-life condition .</brief_summary>
	<brief_title>An Observational Study Assess Patient Satisfaction Control Psoriasis With Calcipotriene/Betamethasone Dipropionate ( Taclonex速 ) Topical Suspension , Effect Quality Life</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>1 . Signed date informed consent obtain prior study related activity 2 . Aged 18 year 3 . Either sex 4 . Any race ethnicity 5 . Attending hospital outpatient clinic private practice boardcertified dermatologist , dermatologycertified nurse practitioner physician assistant train dermatology 6 . Clinical diagnosis psoriasis vulgaris involve scalp and/or body amenable treatment maximum 100 g topical medication per week . 7 . Patients receive prescription calcipotriene/betamethasone dipropionate ( Taclonex速 ) topical suspension 0.005 % / 0.064 % per investigator 's clinical judgment accordance US label , access medication 8 . Able communicate investigator , read understand English , understand comply requirement study 1 . Prior treatment calcipotriene/betamethasone dipropionate ( Taclonex速 ) topical suspension , 0.005 % /0.064 % . 2 . Contraindications warnings/precautions accord US label . 3 . Current participation interventional clinical study . 4 . Females pregnant , breastfeeding , females childbearing potential wishing become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Plaque psoriasis</keyword>
	<keyword>calcipotriene</keyword>
	<keyword>betamethasone dipropionate</keyword>
	<keyword>topical</keyword>
</DOC>